11 August 2022 · Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
24 May 2010 · This audit document is intended to be used to audit Pharmacy aspects of the safe administration of intrathecal chemotherapy, as part of the EL(97)52 Audit…
11 August 2022 · The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk
11 August 2022 · Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration